Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.78 |
| ▸ | CES1 | P23141 | 3/20 | 0.78 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | CA1 | P00915 | 6/20 | 0.61 |
| ▸ | CA2 | P00918 | 6/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.59 |
| ▸ | PARP1 | P09874 | 1/20 | 0.59 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.59 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.59 |
| ▸ | PLK1 | P53350 | 1/20 | 0.55 |
| ▸ | GSK3B | P49841 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL557152 | 0.88 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL14507040 | 0.88 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL5740071 | 0.87 | CES2 (0.72) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL29548151 | 0.86 | CES2 (0.95) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL14886374 | 0.84 | MAPT (0.72) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL2419348 | 0.83 | MAPT (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL8669380 | 0.82 | CES2 (0.86) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL9982878 | 0.82 | CES2 (0.64) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL906482 | 0.82 | CES2 (0.78) | CES2CES1MAPTCA1CA2 | |
| P-Methoxy-Acetophenone SCHEMBL41285 | 0.81 | MAPT (0.70) | CES2CES1MAPTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912606-A | Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119912606-A | Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-115521196-B | Method for preparing alpha-hydroxy ketone compound by using water as hydrogen source | 云南民族大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-115521196-A | Method for preparing alpha-hydroxy ketone compound by taking water as hydrogen source | 云南民族大学 | 2022-12-27 | — | — | CN | disclosed |
| CN-110483586-B | Large steric hindrance ketimine nickel catalyst and ligand compound, preparation method and application thereof | 中国科学技术大学 | 2021-07-09 | — | — | CN | disclosed |
| US-9975831-B2 | Method for producing ether compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2018-05-22 | — | — | US | disclosed |
| CN-107513060-A | The synthetic method of Iloperidone | 山东金城医药化工有限公司 | 2017-12-26 | — | — | CN | disclosed |
| US-9771369-B2 | Compounds and methods for kinase modulation, and indications therefor | PLEXXIKON INC. (US) | 2017-09-26 | — | — | US | disclosed |
| US-9771369-B2 | Compounds and methods for kinase modulation, and indications therefor | PLEXXIKON INC. (US) | 2017-09-26 | — | — | US | disclosed |
| EP-2352725-A1 | QUINOXALINE-BASED LXR MODULATORS | Wyeth LLC (US) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010054229-A1 | QUINOXALINE-BASED LXR MODULATORS | WYETH LLC (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20100120778-A1 | QUINOXALINE-BASED LXR MODULATORS | WYETH (US) | 2010-05-13 | — | — | US | disclosed |
| US-7422837-B2 | Photosensitive composition | FUJIFILM CORPORATION (JP) | 2008-09-09 | — | — | US | disclosed |
| US-7422837-B2 | Photosensitive composition | FUJIFILM CORPORATION (JP) | 2008-09-09 | — | — | US | disclosed |
| US-20080041273-A1 | Scratchproof, Radiation-Curable Coatings | BASF COATINGS AKTIENGESELLSCHAFT (DE) | 2008-02-21 | — | — | US | disclosed |
| EP-1772502-A1 | Oxidatively drying composition to be employed in thin layers comprising 1,2 dioxo compounds | DSMIP Assets B.V. (NL) | 2007-04-11 | — | — | EP | disclosed |
| EP-0611301-A1 | CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1994-08-24 | — | — | EP | disclosed |
| EP-0611301-A4 | CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS. | PROCTER & GAMBLE (US) | 1993-03-01 | — | — | EP | disclosed |
| WO-1991016034-A1 | CHELATOR COMPOSITIONS COMPRISING OXIME COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1991-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120778-A1 | QUINOXALINE-BASED LXR MODULATORS | NR1H2, NR1H3, NR1H4 | CES2 1014/4885CES1 17/4885MAPT 4746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.